文献速递慢性静脉疾病

复杂消肿疗法对慢性静脉功能不全患者静脉血流、内隐静脉直径、水肿、肢体脂肪量及生活质量的效果:一项随机临床试验

Efficacy of complex decongestive therapy on venous flow, internal saphenous diameter, edema, fat mass of the limbs and quality of life in patients with chronic venous insufficiency: A randomized clinical trial.
PubMed 文献 · J Vasc Surg Venous Lymphat Disord · 2024-11-13

一项单盲随机对照试验将慢性静脉功能不全患者随机分为实验组(n=11/22)和对照组(n=9/18),实验组接受为期4周、每周2天的复杂消肿疗法(CDT),对照组不接受治疗。结果显示CDT改善了生活质量评分、症状(沉重感和疼痛)、静脉血流速度,并降低了内隐静脉直径、体重指数和肢体脂肪量,除生活质量改善外,其余效果在6周随访时仍维持。

要点

  • CDT可改善CVI患者的CIVIQ-20和静脉临床严重程度评分。
  • CDT减轻沉重感和疼痛,提高左股静脉和左内隐静脉平均流速。
  • CDT降低双侧内隐静脉直径、体重指数和双下肢脂肪量。

核心结论

  • CDT治疗可改善CIVIQ-20和静脉临床严重程度评分,并改善症状、静脉血流速度,降低体重指数、脂肪量和内隐静脉直径。

研究设计与样本

  • 单盲随机对照试验,慢性静脉功能不全患者随机分为实验组(n=11/22)和对照组(n=9/18)。
  • 实验组接受复杂消肿疗法(手动淋巴引流、间歇气压治疗、双层绷带)4周、每周2天,对照组不接受治疗。
  • 在基线(t0)、干预结束后1周(t1)和干预后6周(t2)进行评估。

主要发现

  • 生活质量改善:症状如沉重感和疼痛减轻。
  • 左股静脉和左内隐静脉平均流速增加。
  • 双下肢内隐静脉直径减小。
  • 体重指数和双下肢脂肪量降低。
  • 上述结果在6周随访时维持,但生活质量改善未维持。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Demonstrate the effectiveness of complex decongestive therapy (CDT) in patients with chronic venous insufficiency (CVI). METHODS: A single-blind randomized controlled trial was conducted, where the participants were patients with CVI (n = 21/42) were assigned randomly to an experimental group (n = 11/22) or a control group (n = 9/18). A treatment of CDT (manual lymphatic drainage, intermittent pneumatic presotherapy, bilayer bandage) was applied to the experimental group for 4 weeks 2 days per week and no treatment was applied to the control group. The patients were evaluated at baseline (t0), 1 week after finishing the intervention (t1), and 6 weeks after the intervention (t2). The effectiveness of the treatment on symptoms and quality of life (QoL) (heaviness, pain and Chronic Venous Insufficiency Quality of Life [CIVIQ-20] questionary), edema, venous flow, and impedanciometry measurements was evaluated. RESULTS: An improvement in the patient's QoL was observed: there was a decrease in symptoms such as heaviness and pain, an increase in the average velocity of the left femoral vein and left internal saphenous vein (ISV), a decrease in the ISV diameter in both extremities and a decrease in body mass index and fat mass in both extremities. These results were maintained when following up at 6 weeks, except for the improvement of QoL. CONCLUSIONS: CDT treatment improves the CIVIQ-20 and Venous Clinical Severity Scores. It also improves symptoms (pain and heaviness), venous flow velocity (superficial veins and deep veins [common femoral vein, femoral vein, popliteal vein]) and decreases body mass index, fat mass, and ISV diameter.

来源:J Vasc Surg Venous Lymphat Disord,查看原文。版权归原作者所有。

引用

  1. Martín Jiménez A, Bermejo Gil BM, Santos-Lozano A, et al. Efficacy of complex decongestive therapy on venous flow, internal saphenous diameter, edema, fat mass of the limbs and quality of life in patients with chronic venous insufficiency: A randomized clinical trial. J Vasc Surg Venous Lymphat Disord. 2024. PMID: 39542398. doi:10.1016/j.jvsv.2024.102005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。